Unveiling disulfidptosis-linked lncRNA signatures: insights into the immune microenvironment and drug responsiveness in oral squamous cell carcinoma
Authors:
Open Access
- 10 November 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1650544
Abstract
Objectives: Oral squamous cell carcinoma (OSCC) has a highly incidence rate and mortality rate all over the world. Hitherto, there are limited studies on survival significance between disulfidptosis-related lncRNAs (DRLs) and OSCC. Therefore, this study was conducted to investigate the potential role of these DRLs and provide some theoretical support in the clinical treatment of OSCC. Methods: OSCC-related lncRNAs and disulfidptosis-related genes (DRGs) were retrieved from public databases. Using Pearson correlation, machine learning, and expression profiling, we identified differentially expressed DRLs (DE-DRLs), developed a DE-DRLs-based risk model and independent prognostic nomogram, performed immunological and tumor microenvironment analyses to explore DE-DRLs regulatory mechanisms, predicted potential drugs for OSCC, and validated bioinformatics findings. Results: In this study, 9 DE-DRLs were identified that correlated with OSCC. The risk model and nomogram showed good clinical utility for assessing the likelihood of OSCC occurrence. Patients exhibiting elevated levels of eosinophils, activated natural killer (NK) cells, or naïve CD4 + T cells experienced significantly poorer overall survival (OS), and patients with high tumor mutational burden (TMB) had worse prognosis. 12 drugs were identified for OSCC treatment, such as BMS-754807_2171 and Foretinib_2040. Conclusion: Our study identified 9 DE-DRLs correlated with OSCC, which will be a personalized prediction tool for prognosis and immune responses in OSCC patients.Keywords
This publication has 59 references indexed in Scilit:
- Integrative bulk RNA analysis unveils immune evasion mechanisms and predictive biomarkers of osimertinib resistance in non-small cell lung cancerDiscover Oncology, 2025
- Construing the role of risk factor-induced oral microbiome dysbiosis in manipulation of lncRNA involved in oral cancerIndian Journal of Otolaryngology and Head & Neck Surgery, 2025
- BRD4 expression and its regulatory interaction with miR-26a-3p, DLG5-AS1, and JMJD1C-AS1 lncRNAs in gastric cancer progressionDiscover Oncology, 2024
- Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loopDiscover Oncology, 2024
- Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinomaComputers in Biology and Medicine, 2024
- Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNAMolecular Biology Reports, 2023
- Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progressionJournal of Advanced Research, 2023
- Key Aspects of Prognostic Model Development and Interpretation From a Clinical PerspectiveJAMA Otolaryngology–Head & Neck Surgery, 2022
- Long non-coding RNA SAP30L-AS1 promotes prostate cancer growth through repressing SAP30LGene, 2019
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001